Modifiable demographic factors that differentiate bronchiolitis from pneumonia in Nepalese children less than two

T Malla1, P Poudyal2, K K Malla1

  • 1Department of Pediatrics, Manipal Teaching Hospital, Phulbari, Pokhara, Nepal.

Insights

This study identified key modifiable risk factors for childhood bronchiolitis and pneumonia, emphasizing the need for targeted prevention strategies to reduce disease burden.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Public health

Background:

  • Bronchiolitis and pneumonia are significant causes of childhood mortality and morbidity.
  • Limited data exists on risk factors in this specific region.
  • Clinical overlap necessitates evaluating demographic differences.

Purpose of the Study:

  • To identify modifiable demographic risk factors for bronchiolitis and pneumonia in children under two years old.

Main Methods:

  • A prospective, comparative hospital-based study conducted from March 2012 to March 2013.
  • 200 cases of bronchiolitis and 200 cases of pneumonia (age 2-24 months) were analyzed.
  • Statistical significance was determined with a p-value < 0.05 using SPSS version 16.

Main Results:

  • Bronchiolitis risk factors: young infant age, prematurity, male sex, younger maternal age, poor maternal knowledge, air pollution, indoor cooking fuel exposure, tobacco smoke, overcrowding, winter season, domestic pets, low birth weight, and animal milk consumption.
  • Pneumonia risk factors: older infant age (13-24 months), maternal age 26-35, female sex, malnutrition, and lack of Vitamin A supplementation and immunization.

Conclusions:

  • Identified risk factors for both diseases are largely modifiable.
  • Prevention of these factors can significantly decrease the burden of bronchiolitis and pneumonia in children.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
64
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391